No praise for folly: Genomics will never be useful in arterial thrombosis

Journal of Thrombosis and Haemostasis

Volumn 5, Issue 3, 2007, Pages 454-457

  Reitsma, P H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; BLOOD CLOTTING FACTOR 5 LEIDEN; CYTOCHROME P450 2C9; EPIDERMAL GROWTH FACTOR RECEPTOR 2; TRASTUZUMAB; WARFARIN;

ANTICOAGULATION; ARTERY THROMBOSIS; ARTICLE; BLEEDING TENDENCY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DNA POLYMORPHISM; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOMICS; GENOTYPE; HEMOSTASIS; HIGH RISK PATIENT; HUMAN; HUMAN GENOME PROJECT; PHARMACOGENOMICS; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; VEIN THROMBOSIS; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; METHODOLOGY; NOTE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHENOTYPE; PREDICTION AND FORECASTING; THROMBOSIS;

ARTERIAL OCCLUSIVE DISEASES; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOMICS; GENOTYPE; HUMANS; PHENOTYPE; PREDICTIVE VALUE OF TESTS; RESEARCH DESIGN; RISK ASSESSMENT; THROMBOSIS;

EID: 34247601107     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2007.02405.x     Document Type: Article

References (18)

1. Guttmacher AE, Collins FS. Realizing the promise of genomics in biomedical research. JAMA 2005; 294: 1399-402.
2. Eco U, Weaver W. Baudolino. New York: Harcourt Inc., 2002.
3. D'Agostino RB, Russell MW, Huse DM, Ellison RC, Silbershatz H, Wilson PW, Hartz SC. Primary and subsequent coronary risk appraisal: New results from the Framingham study. Am Heart J 2000; 139: 272-81.
4. Hemminki K, Lorenzo Bermejo J, Forsti A. The balance between heritable and environmental aetiology of human disease. Nat Rev Genet 2006; 7: 958-65
5. Terwilliger JD, Weiss KM. Confounding, ascertainment bias, and the blind quest for a genetic 'fountain of youth'. Ann Med 2003; 35: 532-44.
6. Ioannidis JP. Why most published research findings are false. PLoS Med 2005; 2: E124.
7. Huizinga TW, Pisetsky DS, Kimberly RP. Associations, populations, and the truth: Recommendations for genetic association studies in arthritis and rheumatism. Arthritis Rheum 2004; 50: 2066-71.
8. Freimer NB, Sabatti C. Guidelines for association studies in human molecular genetics. Hum Mol Genet 2005; 14: 2481-3.
9. Ye Z, Liu EH, Higgins JP, Keavney BD, Lowe GD, Collins R, Danesh J. Seven haemostatic gene polymorphisms in coronary disease: Meta-analysis of 66 155 cases and 91 307 controls. Lancet 2006; 367: 651-8.
10. Lyssenko V, Almgren P, Anevski D, Orho-Melander M, Sjögren M, Saloranta C, Tuomi T, Groop L, the Botnia Study Group. Genetic prediction of future type 2 Diabetes. PLoS Medicine 2005; 2: E345.
11. Janssens AC, Gwinn M, Khoury MJ, Subramonia-Iyer S. Does genetic testing really improve the prediction of future type 2 diabetes? PLoS Med 2006; 3: E114; author reply e27.
12. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, De Ronde H, Van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7.
13. Wu O, Robertson L, Twaddle S, Lowe GD, Clark P, Greaves M, Walker ID, Langhorne P, Brenkel I, Regan L, Greer I. Screening for thrombophilia in high-risk situations: Systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. Health Technol Assess 2006; 10: 1-110.
14. Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J, Helgason A, Stefansson H, Emilsson V, Helgadottir A, Styrkarsdottir U, Magnusson KP, Walters GB, Palsdottir E, Jonsdottir T, Gudmundsdottir T, Gylfason A, Saemundsdottir J, Wilensky RL, Reilly MP et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006; 38: 320-3.
15. Buchanan AV, Weiss KM, Fullerton SM. Dissecting complex disease: The quest for the Philosopher's Stone? Int J Epidemiol 2006; 35: 562-71.
16. Carlson RW, Moench SJ, Hammond ME, Perez EA, Burstein HJ, Allred DC, Vogel CL, Goldstein LJ, Somlo G, Gradishar WJ, Hudis CA, Jahanzeb M, Stark A, Wolff AC, Press MF, Winer EP, Paik S, Ljung BM. HER2 testing in breast cancer: NCCN Task Force report and recommendations. J Natl Compr Canc Netw 2006; 4 (Suppl. 3): S1-22; quiz S23-4.
17. Rettie AE, Tai G. The pharmocogenomics of warfarin: Closing in on personalized medicine. Mol Interv 2006; 6: 223-7.
18. http://smith2.sewanee.edu/erasmus/ME.html (Latin) http://www.stupidity.com/erasmus/declam45.htm (English translation) (accessed 1 February 2007).